A. Rubinstein

发表

Effect of heparin-induced lipolysis on the distribution of apolipoprotein e among lipoprotein subclasses. Studies with patients deficient in hepatic triglyceride lipase and lipoprotein lipase.

W. Brown, G. Kakis, A. Rubinstein, 1985, The Journal of clinical investigation.

Rapid healing of diabetic foot ulcers with continuous subcutaneous insulin infusion.

Z. Bloomgarden, A. Rubinstein, W. Pierce, 1983, The American journal of medicine.

Clearance of chylomicron remnants in normolipidaemic patients with coronary artery disease: case control study over three years

H. Miller, A. Iaina, H. Rotmensch, 1996, BMJ.

Apolipoprotein E-enriched lipoprotein subclasses in normolipidemic subjects.

W. Brown, J C Gibson, A Rubinstein, 1983, Journal of lipid research.

hypercholesterolemia Plasma lipoprotein distribution of apolipoprotein E in familial

R. Goldberg, W. Brown, A. Rubinstein, 2011 .

Abnormalities in lipoprotein metabolism in Gaucher type 1 disease.

H. Ginsberg, N. Le, G. Grabowski, 1988, Metabolism: clinical and experimental.

Plasma Lipoprotein Distribution of Apolipoprotein E in Familial Hypercholesterolemia

R. Goldberg, B. Joffe, W. Brown, 1987, Arteriosclerosis.

Isolation of apolipoprotein E-containing lipoproteins by immunoaffinity chromatography.

W. Brown, A. Rubinstein, J. Gibson, 1986, Methods in enzymology.

In vitro metabolism of apolipoprotein E.

W. Brown, A. Rubinstein, J. Gibson, 1986, Biochimica et biophysica acta.

Immunoaffinity isolation of apolipoprotein E-containing lipoproteins.

I. Goldberg, N. Le, W. Brown, 1985, Biochimica et biophysica acta.

Evidence for non-equilibrating pools of apolipoprotein C-III in plasma lipoproteins.

N. Le, W. Brown, A. Rubinstein, 1985, Journal of lipid research.

Apo E‐Containing Lipoproteins in Low or High Density Lipoprotein Deficiency

R. Norum, H. Greten, W. Brown, 1985, Arteriosclerosis.

Bezafibrate therapy in patients with isolated low high-density lipoprotein cholesterol levels may have a beneficial effect in prevention of atherosclerosis.

A. Iaina, A. Rubinstein, Y. Wollman, 1995, Metabolism: clinical and experimental.

Cholesterol-lowering effects of a 10 mg daily dose of lovastatin in patients with initial total cholesterol levels 200 to 240 mg/dl (5.18 to 6.21 mmol/liter).

Y. Lurie, A. Rubinstein, I. Groskop, 1991, The American journal of cardiology.

Changes in plasma lipids and lipoproteins during isotretinoin therapy for acne.

N. Le, W. Brown, A. Rubinstein, 1985, The New England journal of medicine.

Serum lipids and lipoprotein concentrations during the acute phase of myocardial infarction.

A. Rubinstein, I. Tamir, D. Heldenberg, 1980, Atherosclerosis.

Serum lipids and restenosis after successful percutaneous transluminal coronary angioplasty

H. Miller, G. Keren, D. Sheps, 1994 .

Baseline low-density lipoprotein cholesterol levels and outcome in patients with heart failure.

G. Keren, D. Sheps, O. Rogowski, 2010, The American journal of cardiology.

Fluctuations of lipid and lipoprotein levels in hyperlipidemic postmenopausal women receiving hormone replacement therapy.

N. Maharshak, Y. Ringel, H. Rotmensch, 1998, Archives of internal medicine.

Inverse correlation between coronary and retinal blood flows in patients with normal coronary arteries and slow coronary blood flow.

Y. Arbel, S. Berliner, A. Barak, 2014, Atherosclerosis.

Rapid healing of diabetic foot ulcers with meticulous blood glucose control

A. Rubinstein, W. Pierce, 2007, Acta diabetologia latina.

The erythrocyte adhesiveness/aggregation test for the detection of an acute phase response and for the assessment of its intensity.

I. Shapira, S. Berliner, D. Zeltser, 2002, Clinical and laboratory haematology.

Serum lipids and lipoprotein concentrations in young quadriplegic patients.

A. Rubinstein, I. Tamir, D. Heldenberg, 1981, Atherosclerosis.

Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)

G. Francis, Qian Wang, D. Gaudet, 2021, The Lancet.

Adiponectin and the development of diabetes in patients with coronary artery disease and impaired fasting glucose.

V. Boyko, S. Behar, I. Raz, 2006, European journal of endocrinology.

Antibodies to oxidized LDL as predictors of morbidity and mortality in patients with chronic heart failure.

G. Keren, D. Sheps, A. Afek, 2009, Journal of cardiac failure.

The association of endothelial dysfunction and cardiovascular events in healthy subjects and patients with cardiovascular disease.

Y. Shoenfeld, M. Feinberg, M. Shechter, 2007, The Israel Medical Association journal : IMAJ.

Hormone replacement therapy enhances postprandial lipid metabolism in postmenopausal women.

A. Rubinstein, N. Eckstein, M. Weintraub, 1999, Metabolism: clinical and experimental.

Thyroxine replacement therapy enhances clearance of chylomicron remnants in patients with hypothyroidism.

N. Stern, A. Rubinstein, M. Weintraub, 1999, The Journal of clinical endocrinology and metabolism.

The erythrocyte adhesiveness/aggregation test (EAAT). A new biomarker to reveal the presence of low grade subclinical smoldering inflammation in individuals with atherosclerotic risk factors.

I. Shapira, S. Berliner, D. Zeltser, 2002, Atherosclerosis.

[Lipoprotein associated phospholipase A2].

E. Izkhakov, A. Rubinstein, 2011, Harefuah.

Comparative analysis of the predictive power of different endothelial progenitor cell phenotypes on cardiovascular outcome.

G. Keren, A. Afek, S. Schwartzenberg, 2010, World journal of cardiology.

Precipitation of apo E-containing lipoproteins by precipitation reagents for apolipoprotein B.

W. Brown, A. Rubinstein, J. Gibson, 1984, Clinical chemistry.

Red blood cell adhesiveness/aggregation, C-reactive protein, fibrinogen, and erythrocyte sedimentation rate in healthy adults and in those with atherosclerotic risk factors.

I. Shapira, S. Berliner, D. Zeltser, 2002, The American journal of cardiology.

Serum lipids as minor determinants of the degree of erythrocyte adhesiveness/aggregation in the peripheral blood of individuals with low grade inflammation and moderately increased serum lipids.

I. Shapira, S. Berliner, D. Zeltser, 2004, Clinical hemorheology and microcirculation.

Effect of chronic cholesterol loading in the development of acute ischemic renal failure in rats.

I. Serban, S. Cabili, A. Iaina, 1994, Renal failure.

Effective intestinal absorption of insulin in diabetic rats using a new formulation approach

E. Touitou, A. Rubinstein, M. Donbrow, 1980, The Journal of pharmacy and pharmacology.

Vitamin A loading--an indicator of post-prandial lipoprotein clearance in healthy and hypertriglyceridemic subjects.

M. Liron, A. Rubinstein, M. Weintraub, 1992, Israel journal of medical sciences.

Inhibition of lymphocyte response to mitogens by dipyridamole: Preliminary findings

V. Zakuth, Z. Spirer, A. Rubinstein, 2004, European Journal of Clinical Pharmacology.

Targeted enteral delivery of insulin to rats

E. Touitou, A. Rubinstein, E. Touítou, 1986 .

[Guidelines for the prevention and treatment of atherosclerosis and cardiovasculer diseases: general recommendations--hypertension].

D. Harats, A. Rubinstein, R. Bitzur, 2005, Harefuah.

Molecular genetics of familial hypercholesterolemia in Israel - revisited.

S. Humphries, D. Harats, V. Meiner, 2017, Atherosclerosis.

The effect of HMG-CoA reductase inhibitors on naturally occurring CD4+CD25+ T cells.

G. Keren, G. Luboshits, Karin Mausner-Fainberg, 2008, Atherosclerosis.

Treatment of blood hyperviscosity with calcium dobesilate in patients with diabetic retinopathy.

C. Viggiano, A. Rubinstein, I. S. Benarroch, 1985, Ophthalmic research.

Lymphocyte sensitisation in nifedipine-induced hepatitis.

H. Rotmensch, M. Liron, A. Rubinstein, 1980, British medical journal.

The concomitant appearance of aggregated erythrocytes, leukocytes and platelets in the peripheral blood of patients with risk factors for atherothrombosis.

I. Shapira, S. Berliner, N. Arber, 2001, Clinical hemorheology and microcirculation.

Clopidogrel attenuates atheroma formation and induces a stable plaque phenotype in apolipoprotein E knockout mice.

G. Keren, A. Afek, J. George, 2009, Microvascular research.

HIF-1&agr; Overexpression and Experimental Murine Atherosclerosis

G. Keren, Jeremy Ben-Shoshan, A. Afek, 2009, Arteriosclerosis, thrombosis, and vascular biology.

Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo.

R. Norum, I. Goldberg, N. Le, 1986, The Journal of clinical investigation.

Lipid profile in trained subjects undergoing complete food deprivation combined with prolonged intermittent exercise

Y. Epstein, O. Shpilberg, A. Rubinstein, 2004, European Journal of Applied Physiology and Occupational Physiology.

Bezafibrate and simvastatin combination therapy for diabetic dyslipidaemia: efficacy and safety

I. Shapira, D. Gavish, A. Rubinstein, 2000, Journal of internal medicine.

Predicting Diabetic Nephropathy Using a Multifactorial Genetic Model

B. Glaser, I. Harman-boehm, T. Pollin, 2011, PloS one.

The Metabolic Effects of Omega-3 Plant Sterol Esters in Mixed Hyperlipidemic Subjects

D. Harats, T. Cohen, H. Cohen, 2010, Cardiovascular Drugs and Therapy.

Pathogenesis and Management of Diabetic Dyslipidemia

E. Meltzer, E. Izkhakov, A. Rubinstein, 2003, Treatments in endocrinology.

The effect of caffeine ingestion on physical performance after prolonged exercise

Y. Shapiro, N. Bashan, B. Falk, 2006, European Journal of Applied Physiology and Occupational Physiology.

Efficacy and Safety of Cerivastatin for Type 2 Diabetes and Hypercholesterolemia

S. Soule, M. Maislos, F. Maritz, 1999 .

The Multiplicity of Atherosclerotic Risk Factors Corresponds to the Appearance of Increased Leukocyte Count in the Peripheral Blood: Relevance to the Pathogenesis of the Disease

I. Shapira, S. Berliner, D. Zeltser, 2001, Journal of cardiovascular risk.

Retinal blood flow velocity in metabolic syndrome

A. Barak, R. Pokroy, Z. Burgansky-Eliash, 2013, Graefe's Archive for Clinical and Experimental Ophthalmology.

INCREASED RETINAL BLOOD FLOW VELOCITY IN PATIENTS WITH EARLY DIABETES MELLITUS

Amiram Grinvald, Zvia Burgansky-Eliash, Adiel Barak, 2012, Retina.

Cutaneous blood flow abnormalities in hypertriglyceridemia.

E. Tur, A. Rubinstein, Y. Politi, 1994, Journal of Investigative Dermatology.

Continuous intravenous heparin administration in humans causes a decrease in serum lipolytic activity and accumulation of chylomicrons in circulation.

S. Eisenberg, Y. Ringel, A. Iaina, 1994, Journal of lipid research.

Usefulness of serum myeloperoxidase in prediction of mortality in patients with severe heart failure.

G. Keren, D. Sheps, H. Guzner-Gur, 2008, The Israel Medical Association journal : IMAJ.

Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo.

R. Norum, I. Goldberg, N. Le, 1986, The Journal of clinical investigation.

Interferon alpha-2a for proliferative diabetic retinopathy after complete laser panretinal photocoagulation treatment.

A. Loewenstein, M. Lazar, I. Rosenblatt, 2004, Ophthalmic surgery, lasers & imaging : the official journal of the International Society for Imaging in the Eye.

Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC).

G. Francis, Qian Wang, D. Gaudet, 2021, Lancet.

Clopidogrel attenuates atheroma formation and induces a stable plaque phenotype in apolipoprotein E knockout mice.

G. Keren, A. Afek, J. George, 2009, Microvascular research.